| Contact Details | #B137 Yonsei Engineering Research Park, Yonsei University, Yonsei-ro 50, Seodaemoon-gu, Seoul 02-364-6585ckr@ckregeon.com |
|---|
CK Biotech (CK Regeon)
Category:
Venture
Main Business Area
CK Biotech, also known as CK Regeon, is a global biotech startup leading the development of neuroprotective and therapeutic agents against neuronal disorders. They have successfully obtained FDA orphan drug designation for their autism treatment candidate (NV01-A02) and are currently preparing for phase 2 clinical trials in Korea.
Find out more companies
Related products
-
-
-
-
VentureAprogen
Their main modalities include SDR-Grafting, Recombinant Protein Fusion, CHIMPS Bispecific Antibodies, SHOCAP Bispecific Antibodies, and Bitargeting Receptor-Antibody Hybrid
-
